Stan Druckenmiller

Druckenmiller walks through a recent Teva Pharmaceuticals position: a boring generic drug company at 6× earnings, with a new CEO pivoting toward biosimilars and branded drugs. Value investors hated the growth pivot; growth investors wouldn't touch a generic company. Nobody owned it. He saw the inflection before the market did — the stock doubled in six months. The lesson: don't look at what a company is today, look at what it might become and how investors will re-rate it.

"If you look at today, you're not going to make any money. If you try and look ahead and what might change and how investors might perceive something ahead."

Asked if you need domain expertise to invest in biotech, his answer is an emphatic no — but you need a trusted expert on your team and the skill to read their level of enthusiasm, not just the data they present. He describes his own intelligence as narrow: he is not a brilliant analyst, he is a decisive actor. He filters people, not spreadsheets.

"My advantage is not IQ, it's trigger pulling."

He credits two mentors — an early Pittsburgh boss who taught him craft, and Soros, who taught him the single most important lesson of his career: position sizing. When he joined Soros, he expected to learn about macro. Instead, he learned that being right or wrong matters far less than how much you make when right and how little you lose when wrong. That asymmetry compounds differently than anything else.

"It's not whether you're right or wrong, it's how much you make when you're right and how much you lose when you're wrong."

Asked to construct a portfolio from zero, he lays out his current macro framework: strong US economy, likely Fed cuts, but historically rich valuations. Against that backdrop: long an eclectic basket of equities, long Japan and Korea, long copper (structural supply deficit plus AI-driven demand), some gold as a geopolitical hedge, and short bonds — not expecting to make money on the short, but using it to hedge the inflation scenario while holding risk assets.

He thinks of most trades in terms of 18 months to 3 years, but will exit in 5 days if the facts change. The rise of systematic players and retail-driven volatility hasn't changed his framework — if anything, short-term violence creates better entry points when it goes against a thesis he holds with conviction. The key is using volatility rather than being a victim of it.

Soros taught him that the crowd is right 80% of the time — you just can't be caught in the brutal other 20%. He gets intellectual satisfaction from the contrarian 20% but admits that's ego, not edge. He doesn't care if a trade is crowded if the thesis and the trend are right. Extreme conviction plus no believers doesn't make him doubt — it makes him more convicted.

"I think contrarianism is overrated. I do like it when I have extreme conviction and no one else believes it. It gives me even more conviction."

His partner introduced him to AI in early 2022. He bought a small Nvidia position. ChatGPT launched two weeks later — he doubled. A Morgan Stanley call confirmed the thesis — he doubled again. He then publicly said he couldn't see selling for 2–3 years. Then the stock hit $800, up from $150, and he sold — couldn't stand the success. It went to $1,400 five weeks later. He describes this as one of his biggest regrets: he violated his own stated time horizon because of short-term P&L discomfort.

"I couldn't stand success. It had gone from 150 to 800. I was long-term in it. I couldn't deal with it and I sold it."

Technical analysis was roughly 5× more effective 30–40 years ago simply because so few people used it. Now that everyone does, the edge is gone. Same with the "bad earnings, stock holds up" signal — once widely taught, it stopped working. He calls both strategies "loved to death". He hasn't abandoned them but no longer relies on them the way he once did. The lesson: an edge exists only as long as it remains non-consensus.

Despite having more pattern recognition and tools than ever, he admits he was a better portfolio manager in his 30s and 40s because he had the courage to size into conviction. Wisdom and capital accumulate; willingness to act on them can quietly erode. He is actively trying to regain that nerve — not for performance, but because the game is more fun when you play it fully.

Despite his track record, he doubted himself as a random accident for more than 15 years. He still gets emotional in drawdowns and still makes the same types of mistakes. The hard-won lesson: at some point the record is long enough and consistent enough that you have to accept it is not luck, stop torturing yourself for 48 hours after every mistake, and move on. The gift is real — the job is to stop fighting it.

"You've been doing this long enough and the record is there long enough that it's no longer like a random accident."